Diehard Bargain Hunter: Novavax, Inc. (NVAX), Foot Locker, Inc. (FL)

Novavax, Inc. (NASDAQ:NVAX) shares were trading lower by 0 percent ($0) at $1.17 a piece in Friday’s session. It had closed the previous session at $1.17. NVAX trades with a P/S ratio of 19.68. This is lower than the industry’s 97.45 but higher compared with the wider sector’s 5.3. A low price-to-sales ratio, typically less than 1.0, is considered a good value. Also, it has an estimated price-earnings (P/E) multiple of 0 and a trailing 12-month price-earnings (P/E) multiple of 0. Shares of NVAX have uptrended 29.71% in the past three months, while the industry overall has moved 22.84% in that time. Novavax, Inc. (NVAX) has a market cap of $330.7 million and over the last 12 months, Novavax, Inc. (NASDAQ:NVAX) has gone weaker by -84.5%. During the last 52 weeks, the (NASDAQ:NVAX) price has been as high as $8.49 and as low as $0.73. Novavax, Inc. earnings have declined with an annualized rate of -43.4% over the last 5 years.

Novavax, Inc. (Mean Target Price: $3.58)

The average 1-year price target for Novavax, Inc. (NVAX) — averaging the work of different analysts — reveals a mean PT of $3.58/share. That’s a potential 205.98 increase relative to where Novavax, Inc. (NASDAQ:NVAX) has been trading recently. The current price is seen ranging between $1.16 and $1.19. There are brokerage firms with lower targets than the average, including one setting a price target of $0.9. And then on the other side of the spectrum one analyst entrenched in the bullish camp has a target as high as $12.

Novavax, Inc. (NVAX) Consensus Recommendation

The collective rating of 2.7 for Novavax, Inc. (NASDAQ:NVAX) also leans strongly towards the neutral end of the spectrum. Of the 7 analysts surveyed by Reuters that track NVAX 6 of them rate its stock a hold. The other 1, though not evenly; between analysts who think you should buy Novavax, Inc. versus those who think you should sell it. A 1 analysts rate it as either a buy or a strong buy, while0 believe that investors should either steer clear of NVAX or, if they already own its stock, sell it.

Is Foot Locker, Inc. (NYSE:FL) Cheap From Peers?

Foot Locker, Inc. (FL) knifed -0.31 percent lower and now trades for $48.42. FL comes in with a P/S ratio of 0.82 that’s below 1, potentially implying that it could be cheap relative to the overall sector (4566.9) and its peers (1.86). Also, it has an estimated price-earnings (P/E) multiple of 8.77 and a trailing 12-month price-earnings (P/E) multiple of 9.91. During the last 52 weeks, the price has been as high as $79.43 and as low as $44.87. Foot Locker, Inc. (NYSE:FL) earnings have risen with a quarterly rate of 6.7% over the last 5 years. Shares of FL have sank -32.83% in the past three months, while the S&P 500 has dropped -36.39% in that time.

Foot Locker, Inc. (Price Objective: $70.6)

Foot Locker, Inc. (NYSE:FL) has a market cap of $6.38 billion and over the last 12 months, FL has declined by -16.11%. The average 1-year price target for (FL) reveals an average price target of $70.6 per share. That’s a potential 45.81 gain from where (NYSE:FL) has been trading recently. There are brokerage firms with lower targets than the average, including one setting a price target of $60. And then on the other side of the spectrum one analyst entrenched in the bullish camp has a target as high as $81.

Analyst Thoughts About Foot Locker, Inc. (NYSE:FL)

The consensus recommendation — averaging the work of 23 analysts — of 2 for Foot Locker, Inc. (FL) points to moderate case. Of the analysts surveyed by Reuters that track Foot Locker, Inc. 9 of them rate its stock a hold. The other 14 are split, though not evenly, between analysts who think you should buy its stock versus those who think you should sell it. A 14 analysts rate it as either a buy or a strong buy, while 0 believe that investors should either steer clear of (NYSE:FL) or, if they already own its stock, sell it.